Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii

References

• Singh YN. Kava: An overview. J Ethnopharmacol 1992; 37(1)13–45
   PubMed Web of Science ®Google Scholar
• Witte S, Loew D, Gaus W. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders. Phytother Res 2005; 19(3)183–188
   PubMed Web of Science ®Google Scholar
• Cairney S, Clough AR, Maruff P, Collie A, Currie BJ, Currie J. Saccade and cognitive function in chronic kava users. Neuropsychopharmacology 2003; 28(2)389–396
   PubMed Web of Science ®Google Scholar
• Nerurkar PV, Dragull K, Tang CS. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells as compared to kavalactones. Toxicol Sci 2004; 79(1)106–111
   PubMed Web of Science ®Google Scholar
• Hu L, Jhoo JW, Ang CY, Dinovi M, Mattia A. Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard. J AOAC Int 2005; 88(1)16–25
   PubMed Web of Science ®Google Scholar
• Bobeldigjk I, Boonzaaijer G, Spies-Faber EJ, Vaes WH. Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr A 2005; 1067(1–2)107–114
   PubMed Web of Science ®Google Scholar
• Clough AR, Jacups SP, Wang Z, Burns CB, Bailie RS, Cairney SJ, Collie A, Guyula T, McDonald SP, Currie BJ. Health effects of kava use in an eastern Arnhem Land Aboriginal community. Int Med J 2003; 33(8)336–340
   Google Scholar
• Perez J, Holmes JF. Altered mental status and ataxia secondary to acute kava ingestion. J Emerg Med 2005; 28(1)49–51
   PubMed Web of Science ®Google Scholar
• Cairney S, Maruff P, Clough AR, Collie A, Currie J, Currie BJ. Saccade and cognitive impairment associated with kava intoxication. Human Psychopharmacology 2003; 18(7)525–533
   PubMed Web of Science ®Google Scholar
• Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev 2003, 1: CD003383
   Google Scholar
• Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.). J Ethnopharmacol 2004; 93(2–3)153–160
   PubMed Web of Science ®Google Scholar
• Jamieson DD, Duffield PH. Positive interaction of ethanol and kava resin in mice. Clin Exper Pharm Phys 1990; 17(7)509–514
   PubMed Web of Science ®Google Scholar
• Almeida JC, Grimsely EW. Coma from the health food store: Interaction between kava and alprazolam. Ann Int Med 1996; 125(11)940–941
   PubMed Web of Science ®Google Scholar
• Wooltorton E. Herbal kava: reports of liver toxicity. CMAJ 2002; 166(6)777
   PubMed Web of Science ®Google Scholar
• Ulbricht C, Basch E, Boon H, Ernst E, Hammerness P, Sollars D, Tsourounis C, Woods J, Bent S. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf 2005; 4: 779–794
   PubMedGoogle Scholar
• Clouatre DL. Kava kava: Examining new reports of toxicity. Toxicol Lett 2004; 150(1)85–96
   PubMed Web of Science ®Google Scholar
• Mathews JD, Riley MD, Fejo L, Munoz E, Munos E, Milns NR, Gardner ID, Powers JR, Ganygulpa E, Gununuwawuy BJ. Effects of the heavy usage of kava on physical health: Summary of a pilot survey in an aboriginal community. Med J Aust 1988; 148: 548–555
   PubMed Web of Science ®Google Scholar
• Russmann S, Barguil Y, Cabalion P, Kritsanida M, Duhet D, Lauterburg BH. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003; 15: 1033–1036
   PubMed Web of Science ®Google Scholar
• Clough AR, Bailie RS, Currie B. Liver function test abnormalities in users of aqueous kava extracts. J Toxicol Clin Toxicol 2003; 41(6)821–829
   PubMed Web of Science ®Google Scholar
• http://www.R-project.org, R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2005.
   Google Scholar
• Kraft M, Spahn TW, Menzel J, Senninger N, Dietl KH, Herbst H, Domschke W, Lerch MM. Fulminant liver failure after administration of the herbal antidepressant kava-kava. Dtsch Med Wochenschr 2001; 126(36)970–972
   PubMed Web of Science ®Google Scholar
• Siest G, Batt AM, Fournel-Gigleux S, Galteau MM, Wellman-Bednawska M, Minn A, Costesec AA. Induction of plasma and tissue enzymes by drugs: Significance in toxicological studies. Xenobiotica 1988; 18(suppl 1)21–34
   PubMed Web of Science ®Google Scholar
• Jhoo JW, Freeman JP, Heinze TM, Moody JD, Schnackenberg LK, Beger RD, Dragull K, Tang CS, Ang CY. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 2006; 54(8)3157–3162
   PubMed Web of Science ®Google Scholar
• Currie BJ, Clough AR. Kava hepatotoxicity with western herbal products: Does it occur with traditional kava use?. Med J Aust 2003; 178(9)421–422
   PubMed Web of Science ®Google Scholar
• Stickel F, Baumüller HM, Seitz K, Vasilakis D, Seitz G, Seitz HK, Schuppan D. Hepatitis induced by kava (Piper methysticum rhizoma). J Hepatol 2003; 39: 62–67
   PubMed Web of Science ®Google Scholar
• Mathews JM, Etherridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30: 1153–1157
   PubMed Web of Science ®Google Scholar
• Gurley JB, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Han IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005; 77(5)415–426
   PubMed Web of Science ®Google Scholar
• Russmann S, Barguil Y, Cabalion P, Rentsch K. Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: Protective effect against environmental carcinogens?. Clin Pharmacol Thera 2005; 77(5)453–454
   PubMed Web of Science ®Google Scholar
• Russmann S, Helbling A. Kava hepatoxicity. Ann Int Med 2001; 135(1)68–69
   PubMed Web of Science ®Google Scholar
• Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005; 352(17)1769–78
   PubMed Web of Science ®Google Scholar
• Teschke R. Kava, kavapyrones and toxic liver injury. Z Gastroenterol 2003; 41(5)395–404
   PubMed Web of Science ®Google Scholar